Since climate change and global warming are wreaking havoc, exposure to climate risk insights is vital because it helps in the right course of action. As a result, Informatica Intelligent Data ...

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in ...

The IDMC conducted an in-depth evaluation of interim safety data from 89 enrolled patients and found no significant safety concerns that would impact the trial's continuation. To date, Daewoong has ...

(RTTNews) - SELLAS Life Sciences Group, Inc. (SLS), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, Thursday ...

GUANGZHOU, China, July 2, 2025 /PRNewswire/ -- Bio-Thera Solutions, Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today ...

A record 75.9 million people are living in internal displacement due to conflict, and nearly half that number is in sub-Saharan Africa, according to a recent report. The report from the Internal ...

Argenx (ARGX) announced that the Phase 3 UplighTED studies evaluating efgartigimod subcutaneous in adults with moderate to severe thyroid eye disease will be discontinued. The decision is based on the ...

Let’s Talk Digital, powered by Global Media Alliance, has entered into a strategic partnership with the Institute of Digital Marketing and Communication Ghana (IDMC), Presto Solutions and YFM to ...

Third Independent Data Monitoring Committee (IDMC) review confirms safety and continuation of the study 94 patients enrolled out of 102 planned across Korea and the U.S. Interim baseline ...

Elicio Therapeutics, Inc., a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, announced that following the Independent Data Monitoring ...